About
0.07AUD+0.00 +1.52%
Closed • Updated at 16:59 GMT+00:00Market Cap$35.18M
Volume928.0K
Beta0.20
RSI33.22
Neurizon Therapeutics Limited — investor relations, events, news, and company updates on 6ix.
Latest News
May 13 2026
Ethics Approval Received for NUZ-001 Oral Liquid P1 Study
Apr 16 2026
Placement of Entitlement Offer Shortfall
Apr 1 2026
NUZ-001 Data Shows Multi-Pathway Protein Clearance
Mar 16 2026
Neurizon announces leadership transition
Feb 26 2026
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
Google Übersetzer